Atyr Pharma Inc (ATYR)

$0.40 -0.13 (-25.33%)
Market Cap 93.17M
Revenue (ttm) 190,000.00
Net Income (ttm) -74.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39,010.53%
Debt to Equity Ratio 0.00
Volume 13,205,755
Avg Vol 1,275,296
Day's Range N/A - N/A
Shares Out 98.05M
Stochastic %K 4%
Beta 0.66
Analysts Sell
Price Target $4.50

Company Profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 731 8389
Fax: 858 731 8394
Address:
10240 Sorrento Valley Road, Suite 300, San Diego, United States
Jack_Danielss
Jack_Danielss May. 13 at 9:21 PM
$ATYR how does a company valued at 40M (currently) and tomorrow after the 10% drop will be valued at circa 36M mcap going to raise $150M to fund the global phase 3?! - not happening imo. It’s a buyout at $1 or delisting/bust
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor May. 13 at 9:17 PM
$ATYR IR hasn’t responded to me if they are going to r/s or request extension by June 2nd. I’m going to take that as a r/s….
0 · Reply
Spiceman63
Spiceman63 May. 13 at 8:56 PM
$ATYR Now all the senior leadership gets 50,000 share options for doing a great job. WTF?
2 · Reply
trader2sde
trader2sde May. 13 at 8:42 PM
$ATYR
0 · Reply
trader2sde
trader2sde May. 13 at 8:42 PM
$ATYR
1 · Reply
trader2sde
trader2sde May. 13 at 8:29 PM
$ATYR
0 · Reply
trader2sde
trader2sde May. 13 at 8:27 PM
$ATYR
0 · Reply
BonprixUltimateGuardians
BonprixUltimateGuardians May. 13 at 8:20 PM
$COKE $CHGG $CSIQ $ATYR show
0 · Reply
RedFuture
RedFuture May. 13 at 8:11 PM
$ATYR people still don’t get that ONLY big investor or BO can take this over 1$ right now, yeah you have to wait at least 1 years before FOMO starts again. Until that you can even see 0.10$ or even lower…
0 · Reply
diggs24
diggs24 May. 13 at 8:08 PM
$ATYR Added over the last 2 days. 20,000@$0.49
0 · Reply
Latest News on ATYR
Ethos Announces Early Lock-Up Release

May 13, 2026, 4:35 PM EDT - 49 minutes ago

Ethos Announces Early Lock-Up Release

LIFE

aTyr Pharma to Participate in Upcoming Investor Conferences

May 13, 2026, 4:01 PM EDT - 1 hour ago

aTyr Pharma to Participate in Upcoming Investor Conferences

aTyr Pharma provides regulatory update on efzofitimod following Type C meeting

2026-05-11T23:05:03.000Z - 1 day ago

aTyr Pharma provides regulatory update on efzofitimod following Type C meeting

aTyr Pharma Transcript: Study update

May 11, 2026, 4:30 PM EDT - 2 days ago

aTyr Pharma Transcript: Study update

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

May 11, 2026, 4:01 PM EDT - 2 days ago

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

aTyr Pharma Inc options imply 14.1% move in share price post-earnings

2026-05-08T18:51:05.000Z - 5 days ago

aTyr Pharma Inc options imply 14.1% move in share price post-earnings

Ethos Reports First Quarter Fiscal Year 2026 Financial Results

May 6, 2026, 4:05 PM EDT - 7 days ago

Ethos Reports First Quarter Fiscal Year 2026 Financial Results

LIFE

Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users

May 5, 2026, 9:07 AM EDT - 8 days ago

Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users

LIFE

Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience

Apr 23, 2026, 9:07 AM EDT - 20 days ago

Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience

LIFE

Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026

Apr 2, 2026, 4:05 PM EDT - 5 weeks ago

Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026

LIFE

Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families

Mar 24, 2026, 4:05 PM EDT - 7 weeks ago

Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families

LIFE

aTyr Pharma Transcript: Leerink Global Healthcare Conference 2026

Mar 11, 2026, 8:00 AM EDT - 2 months ago

aTyr Pharma Transcript: Leerink Global Healthcare Conference 2026

aTyr Pharma reports Q4 EPS (14c), consensus (17c)

2026-03-05T21:05:56.000Z - 2 months ago

aTyr Pharma reports Q4 EPS (14c), consensus (17c)

aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update

Mar 5, 2026, 4:01 PM EST - 2 months ago

aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update

Ethos to Participate in The Citizens Technology Conference

Feb 26, 2026, 4:06 PM EST - 2 months ago

Ethos to Participate in The Citizens Technology Conference

LIFE

Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Feb 25, 2026, 4:05 PM EST - 2 months ago

Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results

LIFE

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 20, 2026, 4:01 PM EST - 2 months ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

Feb 18, 2026, 8:00 AM EST - 3 months ago

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026

Feb 5, 2026, 4:05 PM EST - 3 months ago

Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026

LIFE

The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts.

Feb 3, 2026, 2:46 PM EST - 3 months ago

The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts.

FPS LFTO YSS

aTyr Pharma announces U.S. FDA accepted meeting request for efzofitimod

2026-02-03T13:10:35.000Z - 3 months ago

aTyr Pharma announces U.S. FDA accepted meeting request for efzofitimod

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

Feb 3, 2026, 8:00 AM EST - 3 months ago

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

Insurance platform Ethos Technologies valued at $1.2 billion in Nasdaq debut

Jan 29, 2026, 12:30 PM EST - 3 months ago

Insurance platform Ethos Technologies valued at $1.2 billion in Nasdaq debut

Ethos Announces Pricing of Initial Public Offering

Jan 28, 2026, 10:38 PM EST - 3 months ago

Ethos Announces Pricing of Initial Public Offering

Ethos Technologies prices US IPO at $19/share, Bloomberg News reports

Jan 28, 2026, 9:05 PM EST - 3 months ago

Ethos Technologies prices US IPO at $19/share, Bloomberg News reports

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

Jan 7, 2026, 8:01 AM EST - 4 months ago

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution

Dec 18, 2025, 8:01 AM EST - 5 months ago

Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution

Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders

Dec 15, 2025, 2:45 PM EST - 5 months ago

Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

Dec 8, 2025, 3:25 AM EST - 5 months ago

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

aTyr Pharma Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 2, 2025, 1:00 PM EST - 5 months ago

aTyr Pharma Transcript: Piper Sandler 37th Annual Healthcare Conference

aTyr Pharma Faces Class Action after Clinical Trial Failure Raises Investor Concerns

2025-11-25T15:09:57.000Z - 6 months ago

aTyr Pharma Faces Class Action after Clinical Trial Failure Raises Investor Concerns

aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 10, 2025, 8:00 AM EST - 6 months ago

aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference

aTyr Pharma reports Q3 EPS (26c), consensus (18c)

2025-11-06T21:26:32.000Z - 6 months ago

aTyr Pharma reports Q3 EPS (26c), consensus (18c)

aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update

Nov 6, 2025, 4:01 PM EST - 6 months ago

aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update

aTyr Pharma Inc options imply 21.3% move in share price post-earnings

2025-11-06T20:35:18.000Z - 6 months ago

aTyr Pharma Inc options imply 21.3% move in share price post-earnings

aTyr Pharma reports clinical benefit for efzofitimod across multiple diseases

2025-09-30T10:20:48.000Z - 8 months ago

aTyr Pharma reports clinical benefit for efzofitimod across multiple diseases

Piper Sandler healthcare analysts hold an analyst/industry conference call

2025-09-29T20:40:08.000Z - 8 months ago

Piper Sandler healthcare analysts hold an analyst/industry conference call

aTyr Pharma downgraded to Sector Perform from Outperform at RBC Capital

2025-09-15T20:30:25.000Z - 8 months ago

aTyr Pharma downgraded to Sector Perform from Outperform at RBC Capital

Wells Fargo downgrades aTyr Pharma on efzofitimod Phase 3 failure

2025-09-15T18:00:09.000Z - 8 months ago

Wells Fargo downgrades aTyr Pharma on efzofitimod Phase 3 failure

aTyr Pharma downgraded to Equal Weight from Overweight at Wells Fargo

2025-09-15T17:20:16.000Z - 8 months ago

aTyr Pharma downgraded to Equal Weight from Overweight at Wells Fargo

aTyr Pharma downgraded to Neutral from Buy at Lucid Capital

2025-09-15T17:05:38.000Z - 8 months ago

aTyr Pharma downgraded to Neutral from Buy at Lucid Capital

aTyr Pharma downgraded to Hold from Buy at JonesResearch

2025-09-15T16:40:14.000Z - 8 months ago

aTyr Pharma downgraded to Hold from Buy at JonesResearch

aTyr Pharma downgraded to Neutral from Buy at H.C. Wainwright

2025-09-15T16:10:25.000Z - 8 months ago

aTyr Pharma downgraded to Neutral from Buy at H.C. Wainwright

Jack_Danielss
Jack_Danielss May. 13 at 9:21 PM
$ATYR how does a company valued at 40M (currently) and tomorrow after the 10% drop will be valued at circa 36M mcap going to raise $150M to fund the global phase 3?! - not happening imo. It’s a buyout at $1 or delisting/bust
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor May. 13 at 9:17 PM
$ATYR IR hasn’t responded to me if they are going to r/s or request extension by June 2nd. I’m going to take that as a r/s….
0 · Reply
Spiceman63
Spiceman63 May. 13 at 8:56 PM
$ATYR Now all the senior leadership gets 50,000 share options for doing a great job. WTF?
2 · Reply
trader2sde
trader2sde May. 13 at 8:42 PM
$ATYR
0 · Reply
trader2sde
trader2sde May. 13 at 8:42 PM
$ATYR
1 · Reply
trader2sde
trader2sde May. 13 at 8:29 PM
$ATYR
0 · Reply
trader2sde
trader2sde May. 13 at 8:27 PM
$ATYR
0 · Reply
BonprixUltimateGuardians
BonprixUltimateGuardians May. 13 at 8:20 PM
$COKE $CHGG $CSIQ $ATYR show
0 · Reply
RedFuture
RedFuture May. 13 at 8:11 PM
$ATYR people still don’t get that ONLY big investor or BO can take this over 1$ right now, yeah you have to wait at least 1 years before FOMO starts again. Until that you can even see 0.10$ or even lower…
0 · Reply
diggs24
diggs24 May. 13 at 8:08 PM
$ATYR Added over the last 2 days. 20,000@$0.49
0 · Reply
stefano62
stefano62 May. 13 at 8:08 PM
$ATYR would be this the bottom???
0 · Reply
alexx013
alexx013 May. 13 at 8:07 PM
$ATYR added 0.398
0 · Reply
SlickRick_
SlickRick_ May. 13 at 8:06 PM
$ATYR
1 · Reply
Spiceman63
Spiceman63 May. 13 at 8:02 PM
$ATYR Shocking that they even got invited. https://investors.atyrpharma.com/news-releases/news-release-details/atyr-pharma-participate-upcoming-investor-conferences
0 · Reply
anarquia99
anarquia99 May. 13 at 8:00 PM
$ATYR 500 shares total let’s go
0 · Reply
anarquia99
anarquia99 May. 13 at 7:53 PM
$ATYR buying here just a little bit
0 · Reply
Spiceman63
Spiceman63 May. 13 at 7:51 PM
$ATYR Kyorin Pharmaceuticals should just buy this company for peanuts. https://investors.atyrpharma.com/news-releases/news-release-details/atyr-pharma-announces-collaboration-kyorin-pharmaceutical-co-ltd
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor May. 13 at 7:49 PM
$ATYR stop selling please and thank you
0 · Reply
OriginalTradeonrumor
OriginalTradeonrumor May. 13 at 7:46 PM
$ATYR yeah they are 100000% going to raise funds…and that will increase shares…THE QUESTION-what will be the terms!!
1 · Reply
Unknown_Stuntman
Unknown_Stuntman May. 13 at 7:28 PM
$ATYR if theres going to be an RS it will come before 0.30 hits. If not then maybe plummet to 0.13 then dead cat bounce and RS.
0 · Reply
TraderNice
TraderNice May. 13 at 7:25 PM
$ATYR Yeah, shareholders already approved the increase in authorized shares, so the company has the ability to dilute if they need cash. With the Phase 3 miss and the Nasdaq clock running, they might use that option. Just something to be careful about while this plays out.
0 · Reply
TraderNice
TraderNice May. 13 at 7:22 PM
$ATYR ATYR got the Nasdaq deficiency notice on December 4, 2025. That started their 180-day clock, which runs through June 2, 2026. If they meet the criteria, Nasdaq can grant a second 180-day extension, taking them into late November. So yes - they still have time.
0 · Reply